Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small-for-Size Syndrome”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Testing effectiveness (Phase 2)Looking for participantsNCT07312864
What this trial is testing

Safety and Tolerability Study of a Novel Bioartificial Liver in Liver Failure and Small-for-Size Syndrome

Who this might be right for
Liver FailureSmall-for-Size Syndrome
Beijing Friendship Hospital 12
Post-approval studies (Phase 4)UnknownNCT04107428
What this trial is testing

Somatostatin in Living Donor Liver Transplantation

Who this might be right for
End Stage Liver DIseasePortal Hypertension
King Faisal Specialist Hospital & Research Center 56
Very early researchEnrolling By InvitationNCT07276568
What this trial is testing

Safety, Tolerability, and Preliminary Efficacy of Hepatocyte-like Cell Injection for the Prevention and Treatment of Small-for-Size Syndrome

Who this might be right for
Small-for-size Syndrome
Zhi-Jun Zhu 12
Not applicableStudy completedNCT05459883
What this trial is testing

Splenic Artery Ligation and Portocaval Shunt in Small-for-size Syndrome

Who this might be right for
Small-For-Size Liver SyndromeLigationLiver Regeneration+5 more
Aretaieion University Hospital 13
Not applicableLooking for participantsNCT05339984
What this trial is testing

Hepatic and Systemic Hemodynamic Modeling During Liver Surgery

Who this might be right for
Liver DiseasesLiver Transplantation
Assistance Publique - Hôpitaux de Paris 150
Post-approval studies (Phase 4)Not Yet RecruitingNCT06974344
What this trial is testing

Octreotide vs. Splenic Artery Ligation for Portal Flow Modulation in Living Donor Liver Transplants (SCALOP Trial)

Who this might be right for
Small-for-Size Syndrome
King Faisal Specialist Hospital & Research Center 80